Antipsychotic drug toxicology in children

National Trends in Child and Adolescent Psychotropic Polypharmacy in Office-Based Practice, 1996-2007

(2011) Jonathan S. Comer et al.   JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY

Main contribution of the cytochrome P450 isoenzyme 1A2 (CYP1A2) to N-demethylation and 5-sulfoxidation of the phenothiazine neuroleptic chlorpromazine in human liver—A comparison with other phenothiazines

(2010) Jacek Wójcikowski et al.   BIOCHEMICAL PHARMACOLOGY

Primum non nocere:balancing the risks and benefits of prescribing psychotropic medications for youth with bipolar disorder

(2010) Melissa P. DelBello et al.   BIPOLAR DISORDERS

Metabolic effects of second-generation antipsychotics in bipolar youth: comparison with other psychotic and nonpsychotic diagnoses

(2010) Carmen Moreno et al.   BIPOLAR DISORDERS

Population Pharmacokinetics of Oral Risperidone in Children, Adolescents and Adults with Psychiatric Disorders

(2010) An Thyssen et al.   CLINICAL PHARMACOKINETICS

Olanzapine

(2010) Paul L. McCormack   CNS DRUGS

Atypical Antipsychotic Metabolism and Excretion

(2010) J.J. Sheehan et al.   CURRENT DRUG METABOLISM

Treatment of early-onset schizophrenia

(2010) Anand K Mattai et al.   CURRENT OPINION IN PSYCHIATRY

Atypical Antipsychotics for Acute Manic and Mixed Episodes in Children and Adolescents with Bipolar Disorder

(2010) Manpreet K. Singh et al.   DRUGS

Pediatric Uptake of a Newly Available Antipsychotic Medication

(2010) R. B. Penfold et al.   PEDIATRICS

Therapeutic Drug Monitoring in Pediatrics: How Do Children Differ?

(2010) Stuart MacLeod   THERAPEUTIC DRUG MONITORING

Plasma Clozapine, Norclozapine, and the Clozapine:Norclozapine Ratio in Relation to Prescribed Dose and Other Factors: Data From a Therapeutic Drug Monitoring Service, 1993–2007

(2010) Lewis Couchman et al.   THERAPEUTIC DRUG MONITORING

Antipsychotic prescribing trends: a review of pharmaco-epidemiological studies

(2009) H. Verdoux et al.   ACTA PSYCHIATRICA SCANDINAVICA

Amisulpride treatment of adolescent patients with schizophrenia or schizo-affective disorders

(2009) Fatma Varol Tas et al.   EUROPEAN CHILD & ADOLESCENT PSYCHIATRY

Antipsychotics in children and adolescents: Increasing use, evidence for efficacy and safety concerns

(2009) Benedetto Vitiello et al.   EUROPEAN NEUROPSYCHOPHARMACOLOGY

Cardiovascular disease and diabetes in people with severe mental illness position statement from the European Psychiatric Association (EPA), supported by the European Association for the Study of Diabetes (EASD) and the European Society of Cardiology (ESC)

(2009) M. De Hert et al.   EUROPEAN PSYCHIATRY

Cardiometabolic Risk of Second-Generation Antipsychotic Medications During First-Time Use in Children and Adolescents

(2009) Christoph U. Correll   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Drug-Metabolizing Enzyme Genotypes and Aggressive Behavior Treatment Response in Hospitalized Pediatric Psychiatric Patients

(2009) Cynthia A. Prows et al.   JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY

An Open-Label Study of Aripiprazole: Pharmacokinetics, Tolerability, and Effectiveness in Children and Adolescents with Conduct Disorder

(2009) Robert L. Findling et al.   JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY

Antipsychotic Use in Children and Adolescents: Minimizing Adverse Effects to Maximize Outcomes

(2009) CHRISTOPH U. CORRELL et al.   JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY

Body Mass Index Changes and Chronic Neuroleptic Drug Treatment for Tourette Syndrome

(2009) Roosje S. Degrauw et al.   PEDIATRIC NEUROLOGY

Variants of the dopamine D2 receptor gene and risperidone-induced hyperprolactinemia in children and adolescents

(2009) Chadi A. Calarge et al.   Pharmacogenetics and Genomics

CYP2D6genotyping for psychiatric patients treated with risperidone: considerations for cost–effectiveness studies

(2009) Cristina Rodríguez-Antona et al.   PHARMACOGENOMICS

Optimizing Pediatric Dosing: A Developmental Pharmacologic Approach

(2009) Gail D Anderson et al.   PHARMACOTHERAPY

Large Intraindividual Variability of Olanzapine Serum Concentrations in Adolescent Patients

(2009) Christian J Bachmann et al.   THERAPEUTIC DRUG MONITORING

Pharmacokinetics and Therapeutic Drug Monitoring of Psychotropic Drugs in Pediatrics

(2009) Simona Pichini et al.   THERAPEUTIC DRUG MONITORING

Drug monitoring in child and adolescent psychiatry for improved efficacy and safety of psychopharmacotherapy

(2009) Claudia Mehler-Wex et al.   Child and Adolescent Psychiatry and Mental Health

Double-Blind Comparison of First- and Second-Generation Antipsychotics in Early-Onset Schizophrenia and Schizo-affective Disorder: Findings From the Treatment of Early-Onset Schizophrenia Spectrum Disorders (TEOSS) Study

(2008) Linmarie Sikich et al.   AMERICAN JOURNAL OF PSYCHIATRY

Metabolic and Cardiovascular Adverse Events Associated With Antipsychotic Treatment in Children and Adolescents

(2008) Roger S. McIntyre et al.   ARCHIVES OF PEDIATRICS & ADOLESCENT MEDICINE

Metabolism of Atypical Antipsychotics: Involvement of Cytochrome P450 Enzymes and Relevance for Drug-Drug Interactions

(2008) Liana Urichuk et al.   CURRENT DRUG METABOLISM

Ethical issues in psychopharmacology of children and adolescents

(2008) Michael Koelch et al.   CURRENT OPINION IN PSYCHIATRY

Tolerability of Oral Ziprasidone in Children and Adolescents with Bipolar Mania, Schizophrenia, or Schizoaffective Disorder

(2008) Melissa P. DelBello et al.   JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY

Clozapine Versus “High-Dose” Olanzapine in Refractory Early-Onset Schizophrenia: An Open-Label Extension Study

(2008) Sanjiv Kumra et al.   JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY

Steady-State Pharmacokinetic, Safety, and Tolerability Profiles of Quetiapine, Norquetiapine, and Other Quetiapine Metabolites in Pediatric and Adult Patients with Psychotic Disorders

(2008) Helen R. Winter et al.   JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY

Amisulpride doses and plasma levels in different age groups of patients with schizophrenia or schizoaffective disorder

(2008) MJ Müller et al.   JOURNAL OF PSYCHOPHARMACOLOGY

Clozapine and “High-Dose” Olanzapine in Refractory Early-Onset Schizophrenia: A 12-Week Randomized and Double-Blind Comparison

(2007) Sanjiv Kumra et al.   BIOLOGICAL PSYCHIATRY

Identification of the human cytochrome P450 isoforms mediating in vitro N-dealkylation of perphenazine

(2003) Ole V. Olesen et al.   BRITISH JOURNAL OF CLINICAL PHARMACOLOGY